Delivery Order SPE2DB20D1051-SPE2DB24FD6VJ
- Not listed
- The U.S. Defense Logistics Agency (DLA) awarded a $1,282.77 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of 36,000 units of CREON DR 36,000 unit capsules. This delivery order was issued under an indefinite delivery contract (IDC) previously awarded to Amerisourcebergen Drug Corp with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of 24,000 units of CREON DR 100S capsules. The contract has a potential value of $1,804.94 and a completion date of February 13, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, valued at up to $999,999,999.00 and valid through December...
- The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 36,000 units of CREON DR 4563849287 capsules in 100-count packages. The potential value of this contract is $1,366.89 with a completion date of March 5, 2024. Amerisourcebergen Drug Corp is the prime contractor and no set-aside designation was used for this award. This delivery order is part of a larger indefinite...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 36,000 units of the pharmaceutical product "CREON DR 36,000 UNIT CAPSULE UU 100S." The contract has a ceiling value of $1,521.38 and a performance period through April 8, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) valued up to $999,999,999.00, which serves as...
- The U.S. Defense Logistics Agency (DLA) awarded a $6,042.93 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 36,000 units of CREON DR 36,000 UNIT CAPSULE UU 100S, a pharmaceutical product. The contract has an ultimate completion date of August 2, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that Amerisourcebergen holds with the DLA Troop...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,171.68 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical sourcing and distribution company. The delivery order is for 36,000 units of Creon DR 100s capsules, a brand-name medication. This delivery order was issued against an indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp, which has a potential value of $999,999,999.00 and a performance period...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for 24,000 unit capsules of Creon DR 100s, valued at $2,533.02, with a completion deadline of December 5, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is classified as a child order under a larger contract vehicle. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency issued a $1,610.93 delivery order to AmerisourceBergen Drug Corp on February 27, 2026, for 24,000 unit capsules of Creon DR 100s, with an ultimate completion date of March 2, 2026. The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (IDC), valued at $999,999,999.00 through December 2026, which serves as the primary vehicle for delivering pharmaceutical products and medical supplies to support military healthcare programs globally....
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on December 5, 2025, for the supply of 36,000 units of Creon DR 100s capsules with a ceiling value of $4,655.89. This is a firm fixed price delivery order with no set-aside designation, demonstrating competitive award based on open competition. The contract specifies a place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for 36,000 units of Creon DR 100s capsules valued at $2,177.84, with an ultimate completion date of January 5, 2026. This competitively awarded, non-set-aside contract reflects a firm fixed-price delivery order issued on January 2, 2026, for pharmaceutical supply to support federal medical procurement needs. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken,...
- SPE2DB20D1051Indefinite Delivery Contract
- SPE2DB20D1051-SPE2DB24FD6VJDelivery Order
The Defense Logistics Agency (DLA) awarded a $2,559.38 firm fixed price delivery order to Amerisourcebergen Drug Corp, a for-profit organization, to provide 36,000 units of the pharmaceutical product CREON DR 100S capsules. The delivery order, which has a completion date of January 30, 2024, is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp by DLA with a potential value of $999,999,999.00 and a performance period through December 31, 2025. This IDC serves as the primary contract vehicle for Amerisourcebergen to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. No set-aside designation was used for this particular delivery order.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.6k | 1/29/24 |